XML 68 R27.htm IDEA: XBRL DOCUMENT v3.20.1
STOCKHOLDERS' EQUITY (Tables)
3 Months Ended
Mar. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Composition of Common Stock Capital

a.Common Stock:

Number of shares

Authorized as of

Issued as of

Outstanding as of

March 31,

2020

December 31,

2019

March 31,

2020

December 31,

2019

March 31,

2020

December 31,

2019

Stock of $0.0001 par value:

Common stock

125,000,000

125,000,000

49,599,493

49,081,457

49,599,493

48,898,062

Schedule of Stock Option Activity

A summary of the activity in the stock options granted to employees and members of the board of directors for the three months ended March 31, 2020 and related information are as follows:

Number

of

Options

Weighted

average

exercise

price

Weighted

average

remaining

contractual

term

in years

Aggregate

intrinsic

Value

 

Outstanding as of December 31, 2019

2,112,009

15.44

3.58

168,229

Granted

59,558

101.81

Exercised

(428,300

)

7.72

Forfeited or expired

-

-

Outstanding as of March 31, 2020

1,743,267

20.28

3.76

108,568

 

Vested and expected to vest as of March 31, 2020

2,143,613

17.51

5.64

139,067

 

Exercisable as of March 31, 2020

1,406,616

15.04

2.69

94,018

Schedule of RSU Activity

A summary of the activity in the RSUs granted to employees and directors for the three months ended March 31, 2020 is as follows:

Number of

RSUs

Weighted average

grant date

fair value

Unvested as of December 31, 2019

2,742,589

52.77

Granted

61,524

101.87

Vested

(268,648

)

38.96

Forfeited

(58,611

)

54.27

Unvested as of March 31, 2020

2,476,854

55.45

Schedule of Recognized Stock-Based Compensation Expense

The Company recognized stock-based compensation expenses related to stock options, RSUs and PSUs granted to employees and non-employee consultants and ESPP in the condensed consolidated statement of income for the three months ended March 31, 2020 and 2019, as follows:

Three months ended March 31,

2020

2019

 

Cost of revenues

$

2,273

$

1,354

Research and development

5,378

3,490

Selling and marketing

3,192

2,404

General and administrative

1,930

2,456

 

Total stock-based compensation expense

$

12,773

$

9,704